FDA Inspection 1072870 — Stallergenes
The FDA completed an inspection of Stallergenes on Sep 28, 2018 in Antony. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 28, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Antony (France)